TipRanks
Advertisement
Advertisement
Shanghai Bao Pharmaceuticals Wins NMPA Nod to Begin Trials of Synthetic Biology Ulinastatin BJ044
PremiumCompany AnnouncementsShanghai Bao Pharmaceuticals Wins NMPA Nod to Begin Trials of Synthetic Biology Ulinastatin BJ044
3M ago
Shanghai Bao Pharma Wins U.S. FDA IND Clearance for First Subcutaneous Ceftriaxone Candidate
Premium
Company Announcements
Shanghai Bao Pharma Wins U.S. FDA IND Clearance for First Subcutaneous Ceftriaxone Candidate
4M ago
Shanghai Bao Pharma Wins Priority Review for First-in-Class Kidney Transplant Desensitization Drug KJ103
Premium
Company Announcements
Shanghai Bao Pharma Wins Priority Review for First-in-Class Kidney Transplant Desensitization Drug KJ103
4M ago
Shanghai Bao Pharma Wins NMPA Nod for Recombinant Human Hyaluronidase Injection
PremiumCompany AnnouncementsShanghai Bao Pharma Wins NMPA Nod for Recombinant Human Hyaluronidase Injection
6M ago
Shanghai Bao Speeds KJ017 Toward Market With Regulatory Wins and WuXi Biologics Deal
Premium
Company Announcements
Shanghai Bao Speeds KJ017 Toward Market With Regulatory Wins and WuXi Biologics Deal
6M ago
Shanghai Bao Pharmaceuticals Revamps Board and Governance Structure Ahead of New PRC Company Law
Premium
Company Announcements
Shanghai Bao Pharmaceuticals Revamps Board and Governance Structure Ahead of New PRC Company Law
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―